The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children

Nuhoglu Y., Bahceciler N., Barlan I., Basaran M.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, cilt.86, sa.3, ss.318-322, 2001 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 86 Sayı: 3
  • Basım Tarihi: 2001
  • Doi Numarası: 10.1016/s1081-1206(10)63306-6
  • Dergi Adı: ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.318-322
  • Marmara Üniversitesi Adresli: Hayır

Özet

Background: International guidelines recommend the use of systemic steroids for the treatment of acute asthma attack if it has not been resolved within 24 to 36 hours of home management with regular beta (2) mimetic inhalation. Such therapy for infrequent exacerbations is unlikely to have serious systemic effects. Unfortunately, many patients receiving frequent courses are potentially at risk for corticosteroid-induced side effects such as adrenal suppression, depression of linear growth, and osteoporosis.